Neiry is a group of companies engaged in the development of nearly all types of Brain-Computer Interfaces (BCI) and their applications across multiple industries.
Technologies
Non-medical non-invasive technologies
- Developed 8 devices
- Based on them, launched 5 products to market
- Distribution in over 40 countries worldwide
- Developed over 25 devices and obtained 8 registration certificates, including: FSR 2010/1176 (29.03.2010), RZN 2016/5020 (17.11.2016), FSR 2011/11685 (15.05.2011)
- Introduced more than 50 products to market.
- Assembled a team of leading market experts
- Conducting initial R&D activities
- Planning the development of domestically produced DBS (Deep Brain Stimulation) devices
Medical non-invasive technologies
Invasive technologies
BCI
mBCI
iBCI
Areas of Work
Own laboratories, and operating rooms
Own manufacturing facilities
How We Develop Technologies
20
surgeries per month
2
production sites
9
patents
4
laboratories
2
vivariums
4
neurosurgical
suites
suites
Key Figures
Team
43 scientists
9 physicians
5 veterinarians
Over 100 software engineers
11 hardware designers
Our partners
Develops and commercializes non-invasive and invasive BCIs for consumer, corporate, educational, and medical markets. The strategy includes asset consolidation, development of platform-based solutions (Hardware + API), and active scaling.
Key Technologies and Competencies
- Brain-Computer Interface (BCI): Development and application of BCIs for state monitoring and device control.
- Non-invasive sensing: EEG (dry electrodes, 4−8 channels), PPG (photoplethysmography), MEMS (accelerometer, gyroscope).
- State analysis: Real-time algorithms calculating 25 psychophysiological metrics (focus, relaxation, stress, cognitive load, fatigue, etc.).
- VR/AR integration: Seamless connection of neurointerfaces with virtual and augmented reality headsets.
- Invasive neurotechnologies: R&D in neurostimulation (deep brain, spinal cord, and vagus nerve stimulation) and neurophysiological research on animal models (own labs, partnerships with MSU and Bauman MSTU).
- API Platform: Developer access to raw data and computed metrics for application development.
"Non-invasive Technologies":
"Invasive Technologies" (in development):
- Devices: over 8 models of neuroheadsets (Neiry Headband, Neiry Headphones, Neiry Headband Pro) and VR-integrated solutions.
- Software and Services — Neiry API (Capsule), user apps (Mind Tracker, Brainy).
- Applications (53+ pilot projects) — industrial safety, corporate training and wellbeing, education (EdTech), neuromarketing, mental health, neurofitness, recommender systems, research.
"Invasive Technologies" (in development):
- PUSIN — Prospective Universal System of Invasive Neurostimulation (applications: DBS, SCS, VNS).
- R&D — over 20 neurophysiological operations per month; "Pythia" experiment (brain-AI interface); "NeuroRoga" project.
Founded in 1992, specializes in the development and production of professional medical equipment for neurophysiology, functional diagnostics, and rehabilitation.
Key products include multichannel EEG systems, electromyographs (EMG), cardio-intervalography (KIG) complexes, biofeedback (BFB) systems, multifunctional Kolibri sensors, and SDKs for developers.
The company also manufactures portable devices for home use and for monitoring botulinum toxin injections.
Key products include multichannel EEG systems, electromyographs (EMG), cardio-intervalography (KIG) complexes, biofeedback (BFB) systems, multifunctional Kolibri sensors, and SDKs for developers.
The company also manufactures portable devices for home use and for monitoring botulinum toxin injections.
Перейти на сайт
- Multichannel EEG — recording and advanced analysis (spectral, coherence, topographic mapping, epilepsy detection).
- EMG and Evoked Potentials (EP) — diagnostics of neuromuscular systems (stimulation, surface, needle EMG, motor unit analysis), registration of multimodal EPs.
- Biofeedback (BFB) — EEG-, EMG-, HR-, respiratory-, and GSR-based training protocols and systems using Kolibri sensors.
- Transcutaneous Electrical Nerve Stimulation (TENS) — technologies for pain relief, occlusion restoration, TMJ dysfunction therapy, and sleep apnea mitigation.
- Ultrasound Echoencephaloscopy — diagnosis of intracranial pathologies.
- Injection Control — EMG-guided precise drug administration (e.g., botulinum toxin).
- Biosignal Processing — filtering, artifact suppression, and complex neurophysiological data analysis.
- AI Diagnostics (in progress) — cloud-based storage and analytics (EEG, ECG, EMG) using ML for early diagnosis and forecasting.
Russia’s largest neuromarketing company.
- Manufacturer of proprietary equipment and software for neurophysiological research of content perception (eye-trackers, EEGs, biobracelets, PPG, ECG sensors, etc.).
- Developer of neurodata analysis algorithms, proprietary methods, and metrics.
Перейти на сайт
- Eye-tracking — monitoring gaze direction and eye movements to assess attention, interest, storyline engagement, and stimulus recognition.
- Autonomic indicator analysis — synchronous HR, respiration, skin conductance, and PPG measurements to evaluate emotional engagement and valence.
- EEG — registration of brain bioelectric activity to assess memory potential, cognitive load, and engagement.
- Reaction Time — measurement of priming effects to assess associative strength and stimulus attractiveness.
- Classical marketing research methods — quantitative and qualitative approaches, participant observation, and behavioral analysis combining neurophysiology, verbal feedback, and real-world responses.
Develops and implements invasive neurointerfaces (BCIs) for cattle, creating “cyber-animals.” The technology aims to increase farm productivity and address global food security challenges. The company’s strategy includes scaling to thousands of animals, building autonomous neuro-farms, and developing an agri-innovation ecosystem.
Перейти на сайт
- DBS neurostimulation — invasive brain stimulation to improve physiological processes (milk yield, appetite, stress, activity).
- AI Algorithms — intelligent control of stimulation regimes and productivity forecasting.
- Cyber Cows — cattle with increased milk yield (+15−25%) and reduced operational costs.
- Next-Generation Farms — neuroadaptive farms based on Big Data, IoT, ERP, and computer vision.
- R&D and Pilots — first verified stimulation protocols; pilot neuro-farms planned in the Kaluga and Sverdlovsk regions.
- International Ambitions — expansion to MENA and GCC markets, scaling to 5,000+ head of cattle, and further development toward predictive zoomedicine and autonomous smart farms.
